Athira Pharma

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Athira Pharma Inc

ATHABASCA OIL CORP by Athabasca Oil Corp.

Athabasca Oil Corp

Atha Energy Corp

Athabasca Minerals Inc

Biotech

News

Health Care

Press Releases

General

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Meeting

Earnings

Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates

Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit

Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025

Athira Pharma Announces Reverse Stock Split

ATHA

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Artelo Biosciences

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Biofrontera

Cingulate

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Cocrystal Pharma

Curanex Pharmaceuticals Inc - Common Stock

Curanex Pharmaceuticals

Gelteq

Hoth Therapeutics

IM Cannabis

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lexaria Bioscience

Lipocine

Lyra Therapeutics

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals

ProPhase Labs

Pulmatrix

Q/C Technologies

SenesTech

Traws Pharma

TherapeuticsMD

VYNE Therapeutics

cbdMD

Mizuho

Rodman & Renshaw

Comments

Athira Pharma

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL